×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| IND-SWIFT LTD. | NA | NA | NA | NA | 94.5 | 1.47 |
| SOURCE NATURAL FOODS & HERBAL | NA | NA | NA | NA | 94 | 30.1 |
| MAKERS LABORATORIES LTD. | NA | NA | NA | NA | 86.9 | 9.83 |
Ind-Swift Ltd., with Security Code 524652, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 106.6 | 105.9 | 148.5 | 115.9 | 102.6 | 135.2 | 113.9 | 136.3 | 120.1 | 144.9 |
| Expenses | 88.7 | 97.9 | 130.1 | 104.8 | 98.1 | 120.7 | 110.6 | 121.9 | 112.8 | 147.8 |
| Operating Profit | 17.9 | 8.0 | 18.4 | 11.1 | 4.5 | 14.5 | 3.2 | 14.4 | 7.3 | -2.9 |
| OPM % | 16.79% | 7.51% | 12.39% | 9.61% | 4.38% | 10.71% | 2.83% | 10.57% | 6.1% | -1.99% |
| Other Income | 3.2 | 66.9 | 5.6 | 3.2 | 2.6 | 46.6 | 39.9 | 4.6 | 2.6 | 281.3 |
| Interest | 14.8 | 14.5 | 14.9 | 18.3 | 15.3 | 14.4 | 9.5 | 9.5 | 9.9 | 10.2 |
| Depreciation | 7.3 | 7.2 | 6.7 | 6.7 | 6.8 | 6.9 | 5.4 | 5.4 | 5.6 | 7.2 |
| Profit before tax | -1.0 | -7.5 | 2.4 | -10.7 | -15.0 | 39.8 | 28.2 | 4.1 | -5.5 | -11.6 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1.7% |
| Net Profit | -1.0 | 53.1 | 2.4 | -10.7 | -15.0 | 37.5 | 28.2 | 4.1 | -5.5 | 256.6 |
| EPS in Rs | -0.19 | 9.8 | 0.44 | -1.98 | -2.76 | 6.93 | 5.21 | 0.76 | -1.02 | 47.37 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 103.8 | 106.6 | 105.9 | 148.5 | 115.9 | 102.6 | 135.2 | 113.9 | 136.3 | 120.1 |
| Expenses | 92.9 | 88.7 | 97.9 | 130.1 | 104.8 | 98.1 | 120.7 | 110.6 | 121.9 | 112.8 |
| Operating Profit | 10.9 | 17.9 | 8.0 | 18.4 | 11.1 | 4.5 | 14.5 | 3.2 | 14.4 | 7.3 |
| OPM % | 10.52% | 16.79% | 7.51% | 12.39% | 9.61% | 4.38% | 10.71% | 2.83% | 10.57% | 6.1% |
| Other Income | 1.0 | 3.2 | 66.9 | 5.6 | 3.2 | 2.6 | 46.6 | 39.9 | 4.6 | 2.6 |
| Interest | 15.4 | 14.8 | 14.5 | 14.9 | 18.3 | 15.3 | 14.4 | 9.5 | 9.5 | 9.9 |
| Depreciation | 7.1 | 7.3 | 7.2 | 6.7 | 6.7 | 6.8 | 6.9 | 5.4 | 5.4 | 5.6 |
| Profit before tax | -10.6 | -1.0 | -7.5 | 2.4 | -10.7 | -15.0 | 39.8 | 28.2 | 4.1 | -5.5 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -10.6 | -1.0 | 53.1 | 2.4 | -10.7 | -15.0 | 37.5 | 28.2 | 4.1 | -5.5 |
| EPS in Rs | -1.96 | -0.19 | 9.8 | 0.44 | -1.98 | -2.76 | 6.93 | 5.21 | 0.76 | -1.02 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -7% |
| 3 Years: | 5% |
| TTM: | 309% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 48% |
| 3 Years: | 13% |
| 1 Year: | -34% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 309% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 48% |
| 3 Years: | 13% |
| 1 Year: | -34% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|